[Federal Register Volume 64, Number 11 (Tuesday, January 19, 1999)]
[Notices]
[Page 2903]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-1068]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Hanford Thyroid Disease Study Draft Report
The National Center for Environmental Health (NCEH) of the Centers
for Disease Control and Prevention (CDC) announces the following public
meeting.
Name: Release of Hanford Thyroid Disease Study Draft Report
Time and Date: 7 p.m.-9 p.m., January 28, 1999.
Place: Doubletree Hotel, 802 George Washington Way, Richland,
Washington 99352. Telephone 509/946-7611, fax 509/943-8564.
Status: Open to the public, limited only by the space available.
The meeting room will accommodate approximately 200 people.
Purpose: Investigators from Seattle's Fred Hutchinson Cancer
Research Center (FHCRC) and the CDC will present findings to the
media and general public from the Hanford Thyroid Disease Study
Draft Report. The purpose of the study was to determine if there was
an increased risk for thyroid disease among a randomly selected
study population that was exposed to atmospheric releases of
radioactive iodine-131 from the Hanford Nuclear Site in eastern
Washington State during the 1940s and 1950s. The study, mandated by
Congress, was conducted by a team of scientists at the FHCRC under
contract from the CDC.
Background: In 1986, Freedom of Information Act requests led the
Department of Energy to make public thousands of pages of
documentation indicating that large quantities of radioactive
materials were released into the atmosphere from the Hanford Nuclear
Site. The radioactivity was a byproduct of nuclear weapons
production from December 1944 through 1957. Most of the
radioactivity was released in the form of iodine-131 (I-131), which
concentrates in the thyroid glands of those who eat food
contaminated by it. The amount of I-131 released during this period
was more than half a million curies, prompting concern regarding
thyroid health effects. The government convened a special Hanford
Health Effects Review Panel to review the documents and recommend
steps to evaluate possible health consequences among those who live
near the Hanford Site. Two studies were undertaken as a result of
these recommendations. The first was the Hanford Environmental Dose
Reconstruction Project, which estimated potential radiation doses to
the thyroid among persons exposed to Hanford I-131 releases. The
second was the Hanford Thyroid Disease Study. This study was
designed to determine whether the exposures from Hanford resulted in
an increased risk of thyroid disease in a randomly selected study
population. In late 1989, a contract to perform this study was
awarded to the FHCRC.
FOR FURTHER INFORMATION CONTACT: General information may be
obtained from Mr. Mike Donnelly, Project Officer, Radiation Studies
Branch (RSB), Division of Environmental Hazards and Health Effects
(DEHHE), NCEH, CDC, 4770 Buford Highway, NE, (F-35), Atlanta,
Georgia 30341-3724. Telephone 770/488-7040, fax 770/488-7044.
Technical information may be obtained from Dr. Paul Garbe, RSB.
DEHHE, NCEH, CDC, 4770 Buford Highway, NE, (F-35), Atlanta, Georgia
30341-3724. Telephone 770/488-7040, fax 770/488-7044.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and ATSDR.
Dated: January 8, 1999.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 99-1068 Filed 1-15-99; 8:45 am]
BILLING CODE 4163-18-P